Henry Schein, Inc. (HSIC) Shares Sold by Aperio Group LLC

Aperio Group LLC trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 15.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 76,366 shares of the company’s stock after selling 13,588 shares during the quarter. Aperio Group LLC’s holdings in Henry Schein were worth $5,336,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. FTB Advisors Inc. raised its holdings in shares of Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after buying an additional 742 shares during the last quarter. Trust Co. of Vermont raised its holdings in shares of Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after buying an additional 616 shares during the last quarter. Lee Financial Co raised its holdings in shares of Henry Schein by 100.0% in the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after buying an additional 878 shares during the last quarter. JNBA Financial Advisors raised its holdings in shares of Henry Schein by 100.0% in the third quarter. JNBA Financial Advisors now owns 2,000 shares of the company’s stock valued at $164,000 after buying an additional 1,000 shares during the last quarter. Finally, Westside Investment Management Inc. raised its holdings in shares of Henry Schein by 100.0% in the third quarter. Westside Investment Management Inc. now owns 2,000 shares of the company’s stock valued at $160,000 after buying an additional 1,000 shares during the last quarter. 91.15% of the stock is owned by institutional investors and hedge funds.

A number of research firms recently issued reports on HSIC. Zacks Investment Research raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, January 4th. Royal Bank of Canada dropped their price objective on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a report on Tuesday, November 7th. Jefferies Group reissued a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a report on Friday, October 20th. Stephens assumed coverage on Henry Schein in a report on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price objective for the company. Finally, Morgan Stanley cut Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price objective for the company. in a report on Wednesday, December 6th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $84.23.

In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.19% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at $68.43 on Thursday. The firm has a market capitalization of $10,740.00, a PE ratio of 19.72, a price-to-earnings-growth ratio of 1.85 and a beta of 1.00. Henry Schein, Inc. has a twelve month low of $63.01 and a twelve month high of $93.50. The company has a current ratio of 1.55, a quick ratio of 0.86 and a debt-to-equity ratio of 0.30.

TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Shares Sold by Aperio Group LLC” was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://weekherald.com/2018/02/15/henry-schein-inc-hsic-shares-sold-by-aperio-group-llc.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply